• Expertise in Robotic Surgery
  • Clinical Trial Opportunities
  • Academic-Level Care in a
  • Private Practice Setting
  • On-site Chemotherapy
  • Treatment at: 1150 N. 35th Avenue location
  • Offices Located on Memorial Healthcare System Campuses
The Robotic Approach for Ovarian Cancer

The use of the Da Vinci robotic platform continues to expand into operations previously performed by conventional open techniques. Dr. King, Dr. Nishida and Dr. Brand are currently using the robotic approach. Dr. Brand has recently performed what is thought to be the first Robotic surgical removal of advanced ovarian cancer in Florida, one of the few cancer operations that have previously not been thought to be possible with minimally invasive techniques.
Fewer than 50 patients have undergone advanced ovarian cancer surgery in the reported literature using the robotic platform.

[Robotic approach for ovarian cancer: perioperative and survival results and comparison with laparoscopy and laparotomy. Authors: Magrina JF, et al. Gynecological Oncology April, 2011]

Journal: Gynecol Oncol. 2011 Apr; 121(1):100
Department of Gynecology, Mayo Clinic in Arizona, USA.

This is in contrast to early ovarian cancer or cervical and uterine cancers, which are treated primarily with laparoscopic or robotic methods.

The patient was able to leave the hospital in 48 hours and begin chemotherapy in 1 week. Normally the hospital stay is 5-9 days and chemotherapy is 4 - 5 weeks after this type of surgery.
While not all ovarian cancer patterns are candidates for robotic surgery, Dr. Brand feels that most patients should be offered an attempt at robotic surgery, which could reduce patient discomfort and delays in life saving chemotherapy for patients. Dr. Brand is widely known and published in pioneering surgical techniques in gynecological cancer. He is a Voluntary Assistant Professor at the University of Miami - Miller School of Medicine and has a private consulting practice at Memorial Hospital West.